DOW JONES22,220.60+1168.07 5.55%
S&P 5002,621.83+133.18 5.35%
NASDAQ7,789.64+416.56 5.65%

ZIOPHARM Oncology Q4 EPS $(0.09) Misses $(0.08) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 12.5 percent decrease over losses of $(0.08) per share from

Benzinga · 03/02/2020 21:11

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 12.5 percent decrease over losses of $(0.08) per share from the same period last year.